Combined modality staging for clinically localized adenocarcinoma of the prostate as the basis for patient selection for randomized trials of neoadjuvant chemotherapy

By D'Amico A.V.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 4, 2001-07 ,pp. : 171-172

Elsevier

Access to resources Recommend Favorite

Phased array magnetic resonance imaging for staging clinically localized prostate cancer

By Borre Michael   Lundorf Erik   Marcussen Niels   Langkilde Niels Christian   Wolf Hans  

Acta Oncologica, Vol. 44, Iss. 6, 2005-09 ,pp. : 589-592

Informa Healthcare

Access to resources Recommend Favorite

Molecular staging by RT-PCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer

By Mitsiades Constantine   Lembessis Peter   Sourla Antigone   Milathianakis Constantine  

Clinical and Experimental Metastasis, Vol. 21, Iss. 6, 2004-10 ,pp. : 495-505

Springer Publishing Company

Access to resources Recommend Favorite

State-of-the-art radiotherapy in the management of clinically localized prostate carcinoma

By Bermudez R Scott   Izaguirre Alejandra   Roach Mack  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 103-111

Future Medicine

Access to resources Recommend Favorite

Benign Fibrous Histiocytoma: a rare finding on bone scan staging for prostate adenocarcinoma

By Simon M.A.   Miles B.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 1, 2003-01 ,pp. : 45-47

Elsevier

Access to resources Recommend Favorite